GIT1 유전자 결손 마우스 및 이를 이용한 약물 스크리닝 방법
    1.
    发明授权
    GIT1 유전자 결손 마우스 및 이를 이용한 약물 스크리닝 방법 有权
    通过使用GIT1 KNOCK-OUT MICE作为新的ADHD鼠标模型来注意缺陷性高血压疾病的药物

    公开(公告)号:KR101127756B1

    公开(公告)日:2012-03-23

    申请号:KR1020110089182

    申请日:2011-09-02

    Abstract: PURPOSE: A GIT1 gene deficient mouse and a drug screening method using the same are provided to analyze the reason of the attention-deficit hyperactivity disorder and to decipher various kinds of anxiety disorders and diseases. CONSTITUTION: A drug screening method using a GIT1 gene deficient mouse is as follows. A therapeutic agent candidate material of attention-deficit hyperactivity disorder(ADHD) of mammal except for the human is dosed. After the candidate material is administered, an attention-deficit hyperactivity disorder test of mammal except for the human is performed. The candidate material causing the reduction of the attention deficiency hyperactivity disorder is selected.

    Abstract translation: 目的:提供GIT1基因缺陷小鼠及其使用药物筛选方法,分析注意力缺陷多动障碍的原因,解读各种焦虑症和疾病。 构成:使用GIT1基因缺陷小鼠的药物筛选方法如下。 给予哺乳动物除人之外的注意缺陷多动障碍(ADHD)的治疗剂候选物质。 在施用候选物质之后,进行除人之外的哺乳动物的注意缺陷多动障碍试验。 选择引起注意缺陷多动障碍减轻的候选物质。

Patent Agency Ranking